JZT集团药品流通业务竞争战略研究

发布时间：2018-02-27 11:22

本文关键词： 药品流通竞争战略新版GSP　出处：《山东大学》2015年硕士论文　论文类型：学位论文

【摘要】：医药行业是我国国民经济的重要组成部分,是传统产业和现代产业相结合。医药行业对于保护和增进人民健康、提高生活质量,计划生育、救灾防疫、军需战备以及促进经济发展和社会进步均具有十分重要的作用。随着我国市场经济的高速发展和不断完善,新医改政策,新GMP, GSP的提出,药品流通领域市场竞争的越演越烈,促进了药品流通体制的结构调整和经营模式的现代化,智能化进程,加速了药品流通领域向现代化,规模化,智能化,集约化的高速发展,同时提高了人类的健康水平和社会经济效益。JZT集团是一家以药品、医疗器械、生物制品、保健品等产品批发、零售连锁、药品生产与研发及有关增值服务为核心业务的大型企业集团,是中国医药商业领域具有全国性网络的两家企业之一；已连续多年位列中国医药商业企业前列,中国民营医药商业企业第1位,入围中国企业500强；并于2010年11月2日在上海证券交易所挂牌上市,在行业内处于领先地位。但是随着众多竞争者的不断加入以及最新版的GSP的强制执行,也给JZT集团药品流通业务的发展带来了新的挑战和机遇。由于新版GSP中对于行为规范和硬件的具体要求,因次,对JZT集团进行内外部环境分析,科学的制定和实施有效的企业竞争战略,对于JZT集团药品流通业务在日趋激烈的竞争中获得并保持竞争优势,不断的持续发展有着不可磨灭的现实意义。本文首先对企业管理的相关理论,即企业竞争理论进行了回顾和梳理,提出了本文的研究方法和思路,然后文章主要从JZT集团药品流通业务的内部坏境分析,外部环境分析,当前环境下的竞争战略分析和选择,以及该竞争战略的实施与保障四个维度开展讨论。在外部环境分析中,主要将应用PEST宏观环境分析方法以及波特五力模型微观环境分析方法对JZT集团药品流通业务所处的宏观环境和行业环境进行有效分析。在内部分析中,主要针对JZT集团的组织架构、人力资源、企业文化、财务状况、市场营销、质量管理、物流管理等方面进行分析,找出JZT集团的优势和劣势,进行竞争战略的制定和选择。在制定和选择过程中,主要应用SWOT战略分析工具,认为基于差异化的低成本战略是JZT集团药品流通业务保持目前或获得更大竞争力的最佳战略,最后对竞争战略实施提出了相应的保障措施,以确保战略的顺利实施,实现企业持续发展目标。
[Abstract]:The pharmaceutical industry is an important part of our national economy and a combination of traditional and modern industries. The pharmaceutical industry can protect and promote the health of the people, improve the quality of life, family planning, and disaster prevention. With the rapid development and continuous improvement of the market economy in our country, the new medical reform policy, the new GMP, GSP, and the market competition in the field of drug circulation are becoming more and more intense, as the war preparedness of military supplies and the promotion of economic development and social progress play a very important role. It has promoted the structural adjustment of the drug circulation system and the modernization and intelligentization of the business model, and accelerated the rapid development of the field of drug circulation towards modernization, scale, intelligence and intensification. JZT Group is a wholesale and retail chain of drugs, medical devices, biological products, health products, etc. Drug production and R & D and related value-added services as the core business of large enterprise groups, is one of the two national network of Chinese pharmaceutical commercial enterprises, has been ranked in the forefront of Chinese pharmaceutical commercial enterprises for many years. China's first private pharmaceutical commercial enterprises, listed in the top 500 Chinese enterprises, and listed on the Shanghai Stock Exchange on November 2nd 2010, Is leading the industry. But with the addition of many competitors and the enforcement of the latest version of GSP, It also brings new challenges and opportunities to the development of the drug circulation business of JZT Group. Due to the specific requirements for behavior standards and hardware in the new GSP, this paper analyzes the internal and external environment of the JZT Group. Scientific formulation and implementation of effective enterprise competition strategy, for JZT Group drug circulation business in the increasingly fierce competition to obtain and maintain a competitive advantage. The continuous development has indelible practical significance. Firstly, this paper reviews and combs the related theories of enterprise management, that is, the theory of enterprise competition, and puts forward the research methods and ideas of this paper. Then the article mainly from the JZT group drug circulation business internal bad situation analysis, the external environment analysis, the current environment competition strategy analysis and the choice, And the implementation and protection of the competition strategy are discussed. In the analysis of the external environment, The macro environment and industry environment of the drug circulation business of JZT Group will be effectively analyzed by using the PEST macro-environment analysis method and the Porter's five-force model micro-environmental analysis method. This paper analyzes the organizational structure, human resources, corporate culture, financial situation, marketing, quality management and logistics management of JZT Group, and finds out the advantages and disadvantages of JZT Group. In the process of making and selecting the competition strategy, the author mainly applies the SWOT strategy analysis tool, and thinks that the low cost strategy based on differentiation is the best strategy to maintain the current or gain the greater competitiveness of the drug circulation business of the JZT Group. Finally, the corresponding safeguard measures are put forward to ensure the smooth implementation of the strategy and realize the goal of sustainable development of the enterprise.
【学位授予单位】：山东大学
【学位级别】：硕士
【学位授予年份】：2015
【分类号】：F272;F426.72

【相似文献】